| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 112,338 | 117,192 | 125,693 | 166,878 | | Cost of Revenue | 71,333 | 73,680 | 78,707 | 111,029 | | | Gross Profit | 41,005 | 43,512 | 46,986 | 55,849 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 45,732 | 43,878 | 43,898 | 48,609 | | Non Recurring |
-
| 1 | 2 | 122 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,727) | (367) | 3,086 | 7,118 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17 | 61 | 18 | 34 | | Earnings Before Interest And Taxes | (4,710) | (306) | 3,104 | 7,152 | | Interest Expense | 211 | 272 | 295 | 473 | | Income Before Tax | (4,921) | (578) | 2,809 | 6,679 | | Income Tax Expense | (1,485) | (182) | 1,107 | 2,613 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,436) | (396) | 1,702 | 4,066 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,436) | (396) | 1,702 | 4,066 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,436) | ($396) | $1,702 | $4,066 |
|
0.51% Nasdaq 
Income Statement
